Zobrazeno 1 - 10
of 179
pro vyhledávání: '"Dominic Pilon"'
Autor:
Jessica A. Walsh, Iris Lin, Ruizhi Zhao, Natalie J. Shiff, Laura Morrison, Bruno Emond, Louise H. Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D. Chakravarty, Philip Mease
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 487-499 (2024)
Abstract Background Treatment persistence among patients with psoriatic arthritis (PsA) is essential for achieving optimal treatment outcomes. Guselkumab, a fully human interleukin-23p19-subunit inhibitor, was approved by the United States (US) Food
Externí odkaz:
https://doaj.org/article/5984faa752c244f89c78d0606e965338
Autor:
Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 2, Pp 209-219 (2024)
Abstract Background This study aimed to understand treatment patterns, acute healthcare use, and cost patterns among adults with treatment-resistant depression (TRD) who completed induction treatment with esketamine nasal spray in the United States (
Externí odkaz:
https://doaj.org/article/4a210e41e1194677bac962d23e6beec4
Autor:
Benjamin H. Lowentritt, Carmine Rossi, Erik Muser, Frederic Kinkead, Bronwyn Moore, Patrick Lefebvre, Dominic Pilon, Shawn Du
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 11, Iss 2 (2024)
**Background:** The use of androgen receptor signaling inhibitors, including apalutamide, in combination with androgen deprivation therapy is recommended for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic
Externí odkaz:
https://doaj.org/article/89ca6cb7e129487691a432f47155435f
Autor:
Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, Lilian Diaz, Patrick Lefebvre, Steven R. Feldman
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractPurpose: Real-world data comparing long-term performance of interleukin (IL)-23 and IL-17 inhibitors in psoriasis are limited. This study compared treatment persistence and remission among patients initiating guselkumab versus IL-17 inhibitor
Externí odkaz:
https://doaj.org/article/c8df4e1686614c7997eaa377e7d1cd36
Autor:
Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R. Feldman
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2917-2923 (2023)
Externí odkaz:
https://doaj.org/article/839dba9bdcd44128914a0a56814012fe
Autor:
Dee Lin, Dominic Pilon, Laura Morrison, Aditi Shah, Marie-Hélène Lafeuille, Patrick Lefebvre, Carmela Benson
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 3, Pp 471-480 (2023)
Abstract Background Patient affordability is an important nonclinical consideration for treatment access among patients with schizophrenia. Objective This study evaluated and measured out-of-pocket (OOP) costs for antipsychotics (APs) among Medicaid
Externí odkaz:
https://doaj.org/article/48e6dadcff9148f2b9818d57d3eee70b
Autor:
Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre, Steven R. Feldman
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 4, Pp 1053-1068 (2023)
Abstract Background Biologics have revolutionized the management of psoriasis, but response to treatment varies. Loss of treatment efficacy may occur over time, requiring treatment switching or escalation. Claims data on persistence may be informativ
Externí odkaz:
https://doaj.org/article/ed0c182cb61f465986a7c7bda8397a75
Autor:
Dominic Pilon, Kruti Joshi, John J Sheehan, Miriam L Zichlin, Peter Zuckerman, Patrick Lefebvre, Paul E Greenberg
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249731 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0223255.].
Externí odkaz:
https://doaj.org/article/7f30986dfcb04bc095f71f180f70fa57
Autor:
Carol H. Wysham, Patrick Lefebvre, Dominic Pilon, Mike Ingham, Marie-Hélène Lafeuille, Bruno Emond, Rhiannon Kamstra, Wing Chow, Michael Pfeifer, Mei Sheng Duh
Publikováno v:
BMC Endocrine Disorders, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background Achieving control of glycated hemoglobin (HbA1c), blood pressure (BP), and body weight (BW) remains a challenge for most patients with type 2 diabetes mellitus (T2DM). In clinical trials, canagliflozin (CANA), an inhibitor of sodi
Externí odkaz:
https://doaj.org/article/220b375318bd497db4a40b39160c98cd
Publikováno v:
BMC Psychiatry, Vol 17, Iss 1, Pp 1-18 (2017)
Abstract Background Once-monthly paliperidone palmitate (PP1M) is a long-acting injectable antipsychotic that may increase adherence rates, reduce hospitalizations, and lower medical costs compared to oral atypical antipsychotics (OAAs) among schizop
Externí odkaz:
https://doaj.org/article/b796a52a48b5490a8696bba94289ba06